SOLV
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSolventum Corporation Common Stock (SOLV) [ST]
www.solventum.com ↗▼ 0.38%
prev close
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
Congressional Trades
2
All tracked trades
Members Trading
2
Unique members
Net Activity
-2
0 buys · 2 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-31 | SOLVSolventum Corporation Common Stock | Sell | $15,001 - $50,000 | 180d ago | — | |
| 2025-01-15 | SOLVSolventum Corporation Common Stock | Sell | $1,001 - $15,000 | 525d ago | — |
2025-12-31
James French Hill
SOLV
Amount
$15,001 - $50,000
Filed
180d ago
2025-01-15
Julie Johnson
SOLV
Amount
$1,001 - $15,000
Filed
525d ago
Recent News
Powered by Polygon.io
[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Now
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
Solventum (SOLV) Q3 2025 Earnings Call Transcript
Trade Timeline
Congressional activity, newest first
James French Hill
2025-12-31 · Sale
$15,001 - $50,000
Julie Johnson
2025-01-15 · Sale
$1,001 - $15,000